Publicis lands Razorfish

Share this article:
Publicis will acquire Razorfish, a Microsoft-owned digital and interactive shop, for roughly $530 million, according to joint company statements (pdf here).

Razorfish will continue to operate under its brand name, and retain its management structure, led by CEO Bob Lord. David Deal, a Razorfish spokesperson, said the agency is anticipating “business as usual for Razorfish, including our health practice, and we do not foresee sweeping changes otherwise.”

Publicis will integrate Razorfish into its newly created VivaKi group, which incorporates digital and media assets such as Digitas and Denuo into a “nerve center,” tasked with global talent development and the creation of “a new approach to strategic scale across platforms, partners and technology,” according to the VivaKi website.

The acquisition follows a partnership between Publicis and Microsoft that was announced in June, allowing several of Publicis's agencies within the VivaKi group – which also includes Starcom MediaVest Group and ZenithOptimedia – to use Microsoft's Admira technology for media planning, buying and measurement. Admira is slated to launch during the fourth quarter of this year.

Razorfish's clients include Wyeth, Schering-Plough, Johnson & Johnson and others. The agency has hinted at formalizing its healthcare operations in recent months, but has been unable to comment on that development.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.